Agents for use in the treatment of amyloidosis
US-2023357134-A1 · Nov 9, 2023 · US
US10654792B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10654792-B2 |
| Application number | US-201615383635-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 19, 2016 |
| Priority date | Nov 15, 2012 |
| Publication date | May 19, 2020 |
| Grant date | May 19, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention generally relates to compounds having structure I: wherein x represents alkyl, aryl or het-aryl, each of y independently represents hydrogen or halogen and z represents hydrogen or alkyl. Further, said compounds are inhibitors of MEK 1, 2 and 5. Furthermore, the invention includes methods of making said compounds, compositions including said compounds and uses for inhibiting MEK 1, 2 and 5.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a compound of structure Ia or structure Ib: the method comprising a reaction scheme selected from the group consisting of the following: wherein: X 1 is hydrogen, X 2 is hydrogen, alkyl, aryl or hetaryl, Y 1 is halogen, Z is hydrogen or alkyl, and Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen, or Y 4 and Y 5 are hydrogen, and Y 2 and Y 3 are halogen. 2. The method of claim 1 , wherein Y 4 and Y 5 are hydrogen and Y 2 and Y 3 are fluorine. 3. The method of claim 1 , wherein Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen. 4. A method for preparing an inhibitor of mitogen-activated protein kinase 1, 2 and 5, of structure Ia or structure Ib: the method comprising a reaction scheme selected from the group consisting of the following: wherein: X 1 is hydrogen, X 2 is hydrogen, alkyl, aryl or hetaryl, Y 1 is halogen, Z is hydrogen or alkyl, and Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen, or Y 4 and Y 5 are hydrogen, and Y 2 and Y 3 are halogen. 5. The method of claim 4 , wherein Y 4 and Y 5 are hydrogen and Y 2 and Y 3 are fluorine. 6. The method of claim 4 , wherein Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen. 7. The method of claim 4 , wherein Y 1 and Y 4 are fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen.
having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids · CPC title
with simultaneously increasing the number of carbon atoms in the carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.